DOTA-Bombesin (1-14) (TFA)

Produktübersicht

• Artikelname: DOTA-Bombesin (1-14) (TFA)
• Artikelnummer: MCE-HY-P10729A
• Hersteller Artikelnummer: HY-P10729A
• Alternativnummer: MCE-HY-P10729A-1MG,MCE-HY-P10729A-5MG,MCE-HY-P10729A-10MG,MCE-HY-P10729A-25MG
• Hersteller: MedchemExpress
• Kategorie: Proteine/Peptide

Produktbeschreibung

DOTA-Bombesin (1-14) TFA is composed of chelator DOTA and Bombesin (HY-P0195). DOTA-Bombesin (1-14) TFA is used for research of cancer through combination with radioactive elements. DOTA-Bombesin (1-14)TFA can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs)[1].

Produkteigenschaften

• Molekulargewicht: 2042.28 (free base)
• Reinheit: 98.10
• Formel: C90H136N28O25S.xC2HF3O2
• Target-Kategorie: Radionuclide-Drug Conjugates (RDCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: Peptides